Skip to main content

News and blog posts

19
Feb 2024

Five-year implementation strategy for Hybrid closed loop technologies in England

On January 22, 2024, NHS England published a 5-year implementation strategy for Hybrid closed loop (HCL) technologies following the NICE technology appraisal (TA943) publication. As a rule, commissioners and providers must implement TA recommendations within three months. However, an agreed five-year implementation will allow NHS to build specialist competencies and cost-effective procurement. NHS England will fund integrated care boards to reimburse the use of HCL systems
16
Feb 2024

Recommendations about add-on reimbursement for medical devices in France in January 2024

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in January 2024. Twelve recommendations were published concerning the registration of medical devices or modification of registration conditions with the extension of indications for the medical devices in the List of Reimbursable Products and Services (LPPR). Opinions concern cardiovascular, peripheral vascular, interventional radiology, neurovascular, ophthalmology, men’s health, and endoscopy devices, as well as medical aids.
16
Feb 2024

Publication Digest: Evolving Use of Health Technology Assessment in Medical Device Procurement-Global Systematic Review: An ISPOR Special Interest Group Report

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Cangelosi et al. conducted a systematic review to assess how data from health technology assessments (HTAs) informs procurement decisions for medical devices. By synthesizing evidence from 11 relevant studies, the authors aimed to identify the criteria used in purchasing decisions, highlighting the minimal evidence of HTA influencing procurement. The authors emphasized the unmet need for enhanced transparency, incentivization for publishing procurement-related work, and further research to strengthen the connection between HTA and procurement, ultimately aiming to optimize resource allocation and expand access to innovative medical technologies within healthcare systems.
15
Feb 2024

Med Tech-related technology assessments and clinical guidelines from NICE in January 2024

In January 2024, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance (intravascular lithotripsy in peripheral arterial disease, temperature control after cardiac arrest, and pharyngeal electrical stimulation for neurogenic dysphagia) and one new Diagnostics Guidance (AI-derived software to help clinical decision making in stroke). Furthermore, one Diagnostics Guidance and five clinical guidelines were updated.
13
Feb 2024

Publication Digest: Covering digital health applications in the public insurance system: how to foster innovation in patient care while mitigating financial risks-evidence from Germany

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Groene et al. conducted a comprehensive evaluation of Germany's pioneering policy to include digital health applications in the statutory health insurance system, aiming to assess its impact, highlight challenges, and propose prospective policy options. Through analysis of publicly available data from the Federal Institute for Drugs and Medical Devices and empirical findings published by academic institutions and sickness funds, the authors delineated areas for improvement, such as low prescription rates and temporary reimbursement of applications that lack proven benefit. The authors advocated for value-based pricing and increased budget authority for insurance organizations to foster innovation while ensuring optimal resource allocation in healthcare.
13
Feb 2024

New Order relating to cancer screening programs published in France

In January 2024, the Ministry of Health and Prevention published the Order in the Official Journal of the French Republic updating the cancer screening programs. The new Order replaces the previous one from September 2006 and specifies the implementation conditions for the organized screening programs for breast, colorectal, and cervical cancers.
12
Feb 2024

MTRC released a White Paper with a summary of clinical evidence requirements for the LPPR process for implants and invasive devices in France

In a new White Paper, MTRC identified evidence requirements for national add-on reimbursement via the LPPR List process based on analysis of five recent HAS reports with positive recommendations. Cases included technologies with different levels of added clinical value (II, III, IV, and V). A review of five cases is followed by recommendations in relation to evidence generation for medical technologies in France, and factors influencing the decision-making of HAS. The analysis was performed in February 2024.
09
Feb 2024

Publication Digest: HB-HTA focus in a tertiary hospitals' network in Northern Italy: A three-years experience analysis

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Sharma et al. investigated the state and adoption of Hospital Based Health Technology Assessment (HB-HTA) in hospital management. By administering questionnaires to healthcare professionals, the authors aimed to assess HTA knowledge and analyze perspectives. The results revealed a notable interest in HB-HTA as a strategic tool for supporting clinical and organizational decision-making processes, particularly in the evolving healthcare landscape of Italy with increased funds from the National Recovery and Resilience Plan (NRRP).
09
Feb 2024

New national catalog for genetic tests released in Spain

On January 23, 2024, the Ministry of Health introduced a new national catalog, which guarantees the Spanish population's genetic tests nationwide. Currently, the catalog includes 672 tests in eight disease areas, including adult and pediatric oncohematology, pharmacogenomics, hereditary metabolic and mitochondrial diseases, and others. Twelve more disease areas are expected to be added in 2024.